Journal of Neuroscience, Vol 5, 3025-3029, Copyright © 1985 by Society for Neuroscience
The role of the polymorphonuclear leukocyte in hyperalgesia
JD Levine, J Gooding, P Donatoni, L Borden and EJ Goetzl
The results of recent studies of the mechanism of leukotriene B4- induced
hyperalgesia suggest a dependence on polymorphonuclear leukocytes (PMNLs).
In this study, we addressed the contribution of PMNLs to hyperalgesia
evoked by the peptide chemotactic factors N-
formyl-methionyl-leucyl-phenylalanine (fMLP) and the anaphylatoxin fragment
of the fifth component of the complement pathway (C5a). Local injection of
glycogen, which attracts but does not activate PMNLs, produced a marked
shift to the left (toward lower concentrations) in the concentration
dependence curve of fMLP-induced hyperalgesia. In addition, PMNL repletion
by transfusion with syngeneic PMNLs reestablished fMLP-induced hyperalgesia
in PMNL-depleted rats. Finally, supernatants from rat and human PMNLs, that
had been stimulated with fMLP in vitro, produced hyperalgesia in
PMNL-depleted rats. Preliminary characterization of the
hyperalgesia-inducing activity released by stimulated PMNLs indicated that
it is lipid in nature. The nonsteroidal anti-inflammatory indomethacin did
not attenuate C5a and fMLP-induced hyperalgesia. Thus, the hyperalgesia
produced by fMLP and C5a is similar to that produced by leukotriene B4 in
that it is dependent on PMNLs and independent of the cyclo-oxygenation of
arachidonic acid. Taken together, these data suggest that structurally
diverse PMNL- chemotactic factors produce hyperalgesia by a novel
mechanism, involving PMNL-derived factors.